Cargando…

Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells

About 95% of Glioblastoma (GBM) patients experience tumor relapse as a consequence of resistance to the first-line standard chemotherapy using temozolomide (TMZ). Recent studies reported consistently elevated expression levels of carbonic anhydrase CA2 in recurrent glioblastoma and temozolomide-resi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Kai, Schäfer, Agnes, Zhang, Zhuo, Elsässer, Katharina, Culmsee, Carsten, Zhong, Li, Pagenstecher, Axel, Nimsky, Christopher, Bartsch, Jörg W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745118/ https://www.ncbi.nlm.nih.gov/pubmed/35008590 http://dx.doi.org/10.3390/ijms23010157

Ejemplares similares

Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor
por: Hannen, Ricarda, et al.
Publicado: (2019)

Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis
por: Stillger, Maren Nicole, et al.
Publicado: (2023)

Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide
por: Otte, Katharina, et al.
Publicado: (2022)

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells
por: Evers, Lara, et al.
Publicado: (2023)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017)

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
por: Yoshimoto, Koji, et al.
Publicado: (2012)

MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines
por: Malacrida, Alessio, et al.
Publicado: (2022)

DDRE-13. INHIBITION OF EXTRACELLULAR CARBONIC ANHYDRASES INHIBITS GLIOBLASTOMA CELL INVASION
por: Proescholdt, Martin, et al.
Publicado: (2021)

Overcoming Temozolomide Resistance in Glioblastoma via Enhanced NAD(+) Bioavailability and Inhibition of Poly-ADP-Ribose Glycohydrolase
por: Li, Jianfeng, et al.
Publicado: (2022)

A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines
por: Brandt, Barbara, et al.
Publicado: (2023)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma
por: Liu, Xiaojin, et al.
Publicado: (2022)

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
por: Kopecka, Joanna, et al.
Publicado: (2015)

Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2018)

Roles of Carbonic Anhydrases and Carbonic Anhydrase Related Proteins in Zebrafish
por: Aspatwar, Ashok, et al.
Publicado: (2022)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Aza-BODIPY based carbonic anhydrase IX: Strategy to overcome hypoxia limitation in photodynamic therapy
por: Pewklang, Thitima, et al.
Publicado: (2022)

Radiogenomic Predictors of Recurrence in Glioblastoma—A Systematic Review
por: Corr, Felix, et al.
Publicado: (2022)

Carbonic Anhydrases and Metabolism
por: Supuran, Claudiu T.
Publicado: (2018)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Non-Classical Inhibition of Carbonic Anhydrase
por: Lomelino, Carrie L., et al.
Publicado: (2016)

Acipimox inhibits human carbonic anhydrases
por: Mori, Mattia, et al.
Publicado: (2022)

The carbonic anhydrase of Clostridium autoethanogenum represents a new subclass of β-carbonic anhydrases
por: Pander, Bart, et al.
Publicado: (2019)

Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents
por: Bulli, Irene, et al.
Publicado: (2021)

Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer
por: Tonissen, Kathryn F., et al.
Publicado: (2021)

Dispensabilities of Carbonic Anhydrase in Proteobacteria
por: Ueda, Kenji, et al.
Publicado: (2012)

Carbonic Anhydrases and Their Biotechnological Applications
por: Boone, Christopher D., et al.
Publicado: (2013)

Transport metabolons with carbonic anhydrases
por: Deitmer, Joachim W., et al.
Publicado: (2013)

Carbonic anhydrase under pressure
por: Liljas, Anders
Publicado: (2018)

An Overview of the Bacterial Carbonic Anhydrases
por: Supuran, Claudiu T., et al.
Publicado: (2017)

Polyamines and α-Carbonic Anhydrases
por: Scozzafava, Andrea, et al.
Publicado: (2016)

Multivalent Carbonic Anhydrases Inhibitors †
por: Carta, Fabrizio, et al.
Publicado: (2019)

Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival
por: Gjorgjevski, Marko, et al.
Publicado: (2019)

Polymer–Temozolomide Conjugates as Therapeutics for Treating Glioblastoma
por: Ward, Sarah M., et al.
Publicado: (2018)

Dovitinib enhances temozolomide efficacy in glioblastoma cells
por: Thanasupawat, Thatchawan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_36401i11coi5ni2mpnl8upgnkd